Category
QUALITY
Description
Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy for whom KRAS gene mutation testing was performed
eMeasure ID
First Performance Year
2017
Last Performance Year
Metric Type
Single Performance Rate
National Quality Strategy Domain
ECC
Measure Type
Process
eMeasure UUID
NQF eMeasure ID
NQF ID
1859
Is High Priority?
Not Set True False
Is Inverse?
Not Set True False
Overall Algorithm
Primary Steward
American Society of Clinical Oncology
Submission Methods
Registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Not Set True False
Vendor ID
Is Registry Measure?
Not Set True False
Registry Measure Spec
https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_451_Registry.pdf
Web Interface Measure Spec
Claims Measure Spec